TGF-1β from breast cancer cells activates miRNA-494 in MDSCs, which inhibit phosphatase and tensin homolog (PTEN) and activate the AKT pathway, as reported in a previous mouse model of breast cancer treated with a human breast cancer cell line [52]. Here, PTEN is linked to breast cancer.